Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

Labyrinth fitting on a turbine rotor at WEG’s steam turbine facility in Apex Installation of labyrinth seals on a turbine rotor at WEG's steam turbine facility in Apex Measuring of labyrinth ...

Study Highlights Complex Ocean Conditions Facing World's Most Powerful Tidal Turbine Sep. 27, 2024 — Scientists combined innovative drone technology and boat-based surveys to map out the complex ...

A Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...

Dr. Albritton is a resident physician and Dr. Kingdom is Assistant Professor in the Department of Otolaryngology at Emory University School of Medicine, Atlanta, Ga. Albritton FD, Kingdom TT.

A Chinese company is placing a big bet that the trend of increasingly enormous wind turbines is nowhere near its ending point. SANY, a multinational heavy equipment manufacturing firm, announced a ...

Most stomach polyps are asymptomatic, meaning people do not know they have them until they have an endoscopy. Learn what is ...

(Alliance News) - AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps.

Several mucosal vaccine candidates are being explored in pre-clinical and clinical trials. Results just published on a nasal booster vaccine in mice showed that robust mucosal immune responses were ...

Y&R’s Melody Thomas Scott Promises Nikki’s Nightmare Isn’t Over Jan 11, 2024 The Young and the Restless Y&R’s Lauralee Bell, Michael Damian, and Michelle Stafford Are Back at it Again! Oct ...